A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer

BACKGROUND: The safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of enzalutamide were investigated in patients with castration-resistant prostate cancer (CRPC) in Japan through a multicenter phase I/II study. METHODS: In phase I, patients with progressive metastatic CRPC received...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Clin Oncol
Main Authors: Akaza, Hideyuki, Uemura, Hirotsugu, Tsukamoto, Taiji, Ozono, Seiichiro, Ogawa, Osamu, Sakai, Hideki, Oya, Mototsugu, Namiki, Mikio, Fukasawa, Satoshi, Yamaguchi, Akito, Uemura, Hiroji, Ohashi, Yasuo, Maeda, Hideki, Saito, Atsushi, Takeda, Kentaro, Naito, Seiji
Formato: Artigo
Idioma:Inglês
Publicado: Springer Japan 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967591/
https://ncbi.nlm.nih.gov/pubmed/26793974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-016-0952-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares